29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
The energy transition and a growing need for efficient digital infrastructure are two trends fueling...
Read More >
On Monday, March 16, 2020, Boston Mayor Martin J. Walsh announced that all active construction sites...
Read More >
As we reported in previous alerts (April 26, 2019 and May 9, 2019), all employers with 100 or more e...
Read More >
As esports have remained resilient during the pandemic, investors have shown a commitment to levelin...
Read More >
The Office of Federal Contractor Compliance has been busy this year. In 2019, it has obtained over ...
Read More >
More states are enacting so-called “red flag laws,” which allow certain entities and/or individual...
Read More >